Advances in renal cell carcinoma treatment
The treatment of advanced renal cell carcinoma has been completely changed by the development of new therapeutic modalities during the past 3 years. In this time period six targeted agents have been approved for the treatment of advanced or metastatic disease. Phase 3 data support the use of sunitin...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publishing
2010-02-01
|
| Serija: | Therapeutic Advances in Urology |
| Online pristup: | https://doi.org/10.1177/1756287210364959 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|